
Sanavia Oncology develops novel immunotherapies to help patients facing drug-resistant cancer. Using a proprietary platform that combines artificial intelligence with modern immunology, the company…

Sanavia Oncology develops novel immunotherapies to help patients facing drug-resistant cancer. Using a proprietary platform that combines artificial intelligence with modern immunology, the company…
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week
At Two Bear Capital we believe in partnering with our founders to build the best teams and networks possible. We look forward to hearing from you for our new Head of Business Development in Oncology.
Chief Business Officer / Head of Business Development
AI-Driven Oncology Therapeutics | Strategic Partnerships | Pharma & Biotech Licensing
Sanavia
https://www.sanavia.bio/
Location: Remote (U.S.-based preferred) | HQ presence in New York City as needed
Engagement Type: Advisor, Fractional, Contract-to-Hire, or Full-Time Executive Leadership
About Sanavia
Sanavia is an AI-driven oncology company focused on advancing next-generation cancer therapeutics through the integration of artificial intelligence, translational science, and innovative biologic approaches. The company is developing differentiated oncology programs involving antibody and conjugate technologies designed to address high-value opportunities in precision oncology and targeted therapeutics.
Sanavia is building at the intersection of computational discovery, therapeutic innovation, and strategic collaboration. As the company expands its platform and pipeline, it is seeking a senior business development leader to help establish and execute partnering strategies with pharmaceutical and biotechnology companies globally.
Position Summary
Sanavia is seeking an experienced and highly connected Chief Business Officer or Head of Business Development to lead strategic partnering and external business development initiatives across the company’s oncology portfolio and AI-enabled therapeutic platform efforts.
This individual will play a central role in shaping Sanavia’s corporate growth strategy, helping position the company and its programs to pharmaceutical and biotechnology partners, investors, and strategic collaborators.
The ideal candidate combines:
This role is ideal for a senior executive who thrives in entrepreneurial environments and is excited about helping shape the commercial trajectory of an emerging oncology company.
The position may initially begin in an advisory or fractional capacity with the opportunity to transition into a full-time executive leadership role as the organization grows.
Key Responsibilities
Strategic Business Development
Transaction Leadership
Scientific & Market Positioning
Executive Leadership
Qualifications
Required Experience
Scientific Background
Ideal Candidate Profile
Preferred Backgrounds
Experience with antibody therapeutics, antibody-drug conjugates (ADCs), targeted oncology approaches, biologics, translational oncology, or AI-enabled therapeutic discovery is highly desirable.
Engagement Structure
Sanavia is open to multiple engagement structures depending on candidate profile and availability, including:
Compensation structure will be competitive and may include a combination of cash compensation, milestone incentives, advisory equity, or long-term incentive participation.
Join Sanavia
Sanavia is building the future of AI-driven oncology therapeutics and is seeking a strategic business development leader who can help accelerate the company’s partnerships, visibility, and long-term impact within the pharmaceutical and biotechnology ecosystem.
Interested candidates should submit a resume or executive biography along with a brief summary of relevant oncology partnering, licensing, and transaction experience.